Evogene Ltd Ord (EVGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,543 | 12,988 | 5,626 | 8,329 | 7,495 |
| Marketable Securities | 4,543 | N/A | 10,332 | 3,362 | 2,354 |
| Receivables | 1,702 | 1,882 | 1,993 | 1,790 | 3,291 |
| Inventories | 175 | 210 | 2,111 | 1,955 | 2,152 |
| Other current assets | 0 | 551 | 771 | 13,209 | 1,209 |
| TOTAL | $14,963 | $15,631 | $20,833 | $28,645 | $16,501 |
| Non-Current Assets | |||||
| PPE Net | 737 | 812 | 1,196 | 1,359 | 1,621 |
| Investments And Advances | 576 | 614 | 162 | 180 | 242 |
| Intangibles | 0 | 0 | 0 | 0 | 11,955 |
| Other Non-Current Assets | 1,672 | 2,989 | 3,895 | 3,742 | 3,985 |
| TOTAL | $2,985 | $4,415 | $5,253 | $5,281 | $17,803 |
| Total Assets | $17,948 | $20,046 | $26,086 | $33,926 | $34,304 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,945 | 1,088 | 1,102 | 1,077 | 1,205 |
| Accrued Expenses | 922 | 861 | 1,059 | 1,773 | 1,622 |
| Other current liabilities | 1,822 | 762 | 1,222 | 11,664 | 11,893 |
| TOTAL | $5,364 | $3,444 | $4,075 | $15,194 | $15,599 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 21 | 17 | 17 | N/A | 209 |
| Other Non-Current Liabilities | 4,552 | 4,599 | 3,359 | 6,477 | 6,626 |
| TOTAL | $4,594 | $4,627 | $4,759 | $6,357 | $6,310 |
| Total Liabilities | $9,958 | $8,071 | $8,834 | $21,551 | $21,909 |
| Shareholders' Equity | |||||
| Common Shares | 708 | 488 | 489 | 488 | 372 |
| Retained earnings | -288,426 | -282,556 | -277,247 | -281,121 | -276,658 |
| Other shareholders' equity | 10,535 | 12,057 | 16,110 | 15,925 | 16,040 |
| TOTAL | $7,990 | $11,975 | $17,252 | $12,375 | $12,395 |
| Total Liabilities And Equity | $17,948 | $20,046 | $26,086 | $33,926 | $34,304 |